| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10792-016-0389-Y |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10792-016-0389-y |
| P698 | PubMed publication ID | 27830398 |
| P2093 | author name string | Satoshi Kato | |
| Yasuko Uchigata | |||
| Shigehiko Kitano | |||
| Jun Shoji | |||
| Makiko Katagiri | |||
| P2860 | cites work | Disappearance of diabetic macular hard exudates after hemodialysis introduction | Q33250012 |
| Ischemic diabetic retinopathy as a possible prognostic factor for chronic kidney disease progression | Q34200349 | ||
| Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. | Q34397753 | ||
| Diabetes and advanced glycation endproducts | Q34521835 | ||
| High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy | Q35108807 | ||
| Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales | Q35226427 | ||
| Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy | Q36196652 | ||
| TAGE (toxic AGEs) theory in diabetic complications | Q36483059 | ||
| Advanced glycation end-products stimulate basic fibroblast growth factor expression in cultured Müller cells | Q36610702 | ||
| sRAGE and risk of diabetes, cardiovascular disease, and death | Q36867450 | ||
| Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study. | Q37235902 | ||
| Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). | Q39656639 | ||
| Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells | Q40140537 | ||
| Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients | Q44131522 | ||
| The RAGE axis in early diabetic retinopathy | Q46618798 | ||
| Upregulation of RAGE and its ligands in proliferative retinal disease | Q46858627 | ||
| Soluble receptor for advanced glycation end products in patients with decreased renal function. | Q46954195 | ||
| Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients | Q57825335 | ||
| Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface | Q67854285 | ||
| Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes | Q71215521 | ||
| Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products | Q79655377 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1247-1255 | |
| P577 | publication date | 2016-11-09 | |
| P1433 | published in | International Ophthalmology | Q15763839 |
| P1476 | title | Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy. | |
| P478 | volume | 37 |
| Q61811294 | Review of Biomarkers in Ocular Matrices: Challenges and Opportunities | cites work | P2860 |
Search more.